INTRODUCTION
Circumstantial evidence has, for some time, implicated human cytomegalovirus (HCMV) infection as a co-factor for progression to AIDS in human immunodeficiency virus (HIV) infection (Curran et al., 1985; Nelson et al., 1988; Webster, 1991) . There is a well-established interaction between HCMV and HIV using transfection assays in vitro (Duclos et al., 1989; Ho et al., 1990; Jault et al., 1994; Koval et al., 1991) . Generally, it has been shown that infection of cell lines with HCMV upregulates expression from the HIV-1 long terminal repeat (LTR) in transfection/superinfection assays (Duclos et al., 1989; Ho et al., 1990) . Such studies have emphasized the role of the HCMV immediateearly (IE) gene products in the activation of the HIV-1 LTR (Davis et al., 1987; Rando et al., 1990; Walker et al., 1992) . However, many of these analyses have used cell lines that are permissive for HCMV but not normally permissive for HIV-1 infection. Some transfection/superinfection assays have also shown specific differences in the effects of HCMV on HIV-1 infection depending on the cell type used and the relative levels of HIV-1 Tat and HCMV IE gene products in the co-infected cells (Jault et al., 1994; Moreno et al., 1997) and have also suggested that activation of the HIV-1 LTR by HCMV depends on whether the LTR reporter construct used is integrated into host genomic DNA or not (Koval et al., 1995) . However, such assays were carried out using HIV-1 pseudotypes in cell lines that are not normally permissive for HIV-1 infection (Koval et al., 1995) .
Cells of the myeloid lineage are one cell type that can be co-infected with HCMV and HIV in vitro (Nelson et al., 1988) and good evidence now exists as to the importance of myeloid cells in the carriage of both latent HIV (Meltzer et al., 1990; Donaghy et al., 2003) and HCMV in vivo (Reeves et al., 2005) . It has been shown that HCMV infection of peripheral blood monocyte-derived macrophages (MDMs) increases HIV-1 production (Lathey et al., 1994) . However, it is not clear why HIV-1 production is increased in MDMs following co-infection with HCMV and particularly why this appears to conflict with reports of inhibition of HIV-1 production by HCMV in fibroblasts using pseudotyped HIV-1 (Koval et al., 1991) . Also, it is known that only a small proportion of MDMs can generally be infected with HCMV; hence, it is unclear whether the increase in HIV-1 production occurs specifically in the HCMV-infected cells.
Consequently, we analysed the effect that HCMV infection has on subsequent HIV-1 infection in myeloid cells, which are accepted to be important cell types for the carriage of both viruses in vivo. In particular, we assessed whether co-infection of the same cell with HCMV and HIV-MN, a myelotropic strain of HIV-1, had any effect on HIV-1 production. Our data demonstrated that HCMV-infected primary MDMs and differentiated THP1 cells displayed reduced permissiveness for superinfection with HIV-MN. In contrast, uninfected bystander cells were permissive to HIV-MN infection, displaying increased levels of HIV-1 Gag. Analysis of HIV-1 co-receptor expression levels on HCMV-infected and uninfected bystander MDM and THP1 cells demonstrated decreased CCR5 expression on HCMVinfected cells reflecting a significant decrease in total CCR5 protein levels. In contrast, uninfected bystander cells displayed increased cell-surface expression of CCR5 that was, in part, mediated by soluble factor(s) produced from HCMV-infected cultures.
METHODS
Cell lines. HFFs (primary human foreskin fibroblasts; ECACC) were maintained in Eagle's minimal essential medium (Gibco-BRL) supplemented with 10 % fetal calf serum (FCS; Gibco-BRL) at 37 uC, 5 % CO 2 . THP1 cells, a myelomonocytic cell line, were maintained in RPMI 1640 (Gibco-BRL) supplemented with 10 % FCS, 100 U penicillin ml 21 and 100 mg streptomycin (Life Technologies) ml
21
and passaged twice a week. THP1 cells were differentiated overnight in RPMI 1640 supplemented with 10 ng phorbol myristate acetate (PMA; Sigma) ml 21 to a macrophage-like phenotype that was fully permissive for HCMV infection, as described previously (Weinshenker et al., 1988; Turtinen & Seufzer, 1994) .
Primary human MDMs. Primary human MDMs were generated as described previously (Lathey & Spector, 1991) . Briefly, peripheral blood mononuclear cells (PBMCs) were isolated by density-gradient centrifugation using Ficoll-Hypaque (Nycomed Pharma AS). Primary monocytes were obtained by adherence for 1?5 h at 37 uC, 5 % CO 2 . Following adherence, monocytes were cultured in Iscove's modified Dulbecco's media (Gibco-BRL) supplemented with 15 % horse serum (Sera-Lab), 15 % FCS, 2 mM L-glutamine (Gibco-BRL), 100 U penicillin ml
, 100 mg streptomycin ml 21 and 5610 25 M hydrocortisone sodium succinate (Sigma) for 5 days at 37 uC, 5 % CO 2 . After 5 days, cultures were stimulated with 10 ng PMA ml 21 overnight to induce differentiation to HCMV-permissive macrophages.
Viruses. HCMV stocks were generated and infectious units assessed in HFFs. Green fluorescent protein (GFP)-tagged HCMV was a generous gift from Richard Greaves (Imperial College Faculty of Medicine, London, UK) and has been described previously (Murphy et al., 2002) . Briefly, CR[IE1-GFP] is a recombinant Towne strain of HCMV expressing enhanced GFP fused to the C terminus of IE1 p72 protein. The laboratory-adapted strain AD169, the endothelialcell-tropic clinical isolate TB40/E and the low-passage laboratory strain Toledo were used where stated and have been described previously (Sinclair et al., 2000; Sinzger et al., 2000) . HCMV viral titres were determined by plaque assay on HFFs. The macrophagetropic strain of HIV-1 (HIV-MN) (MRC AIDS directed programme) was propagated in H9 lymphoblastoid cells (CFAR/NIBSC).
Co-infection of HCMV and HIV-1. Differentiated THP1 and MDM cells were inoculated with HCMV (m.o.i. of 5-10) or mock inoculated with medium alone and cultured in appropriate medium for 48 h. HCMV-infected cultures were subsequently co-infected with the macrophage-tropic HIV-MN strain for 72 h. (Baillie et al., 2003) at 72 h after HIV-1-infection. HCMV infection was assessed by IE gene expression (if infected with AD169, Toledo or TB40/E) using an FITC-conjugated mouse anti-IE72/IE86 antibody (subclass IgG2a, 1 : 50 dilution; Chemicon). HIV-1 infection was analysed using a mouse monoclonal anti-HIV-1 p24 antibody (clone 3818.7.47, subclass IgG1, 2 mg ml 21 ; Abcam) and visualized with a goat anti-mouse tetramethylrhodamine B isothiocyanate (TRITC)-labelled secondary antibody (1 : 40 dilution; Sigma). All staining was carried out in parallel with appropriate mouse IgG isotype-matched control antibodies.
For some experiments, differentiated THP1 cells were inoculated with CR[IE1-GFP] or Toledo and cell-free supernatants were harvested at 48 h p.i. Supernatants were centrifuged to ensure removal of cell debris, UV inactivated and filtered through a 0?2 mm sterile filter. Differentiated and uninfected THP1 cells were then cultured in the presence of these supernatants (HCMV-conditioned media) for 48 h or in supernatants from mock-infected cells. Both HCMV-infected THP1 cells and THP1 cells incubated with cell-free supernatants were surface stained to detect CCR5 as described above.
Western blot analysis. THP1 cells differentiated with PMA were inoculated with HCMV AD169 (m.o.i. of 5-10). At 48 h after HCMV infection, cultures were inoculated or mock inoculated with the macrophage-tropic HIV-MN. At 72 h p.i., cultures were washed in PBS and resuspended at a concentration of 1610 5 cells in 20 ml SDS lysis buffer. Cells were sonicated for 2 min and resolved by 10 % SDS-PAGE. Proteins were then transferred to nitrocellulose membranes overnight. Membranes were blocked for 30 min with 5 % non-fat dried milk in PBS/0?1 % Tween 20. Western blot analysis was carried out using a mouse anti-Gag antibody (ADP313, 1 : 200 dilution) or a mouse anti-IE72/IE86 antibody detected with the appropriate horseradish peroxidase (HRP)-conjugated antibody (1 : 10 000 dilution; Santa Cruz Biotechnology). Analysis of CCR5 protein levels in HCMV-infected and bystander populations was carried out at 48 h p.i. Differentiated THP1 cells were infected with CR[IE1-GFP] and sorted using a Becton Dickinson FACSort into GFP-positive and -negative (bystander) populations. CCR5 protein levels were detected using a rabbit anti-CCR5 antibody (1 : 1000 dilution; AnaSpec). Confirmation of equal protein loading was carried out using a rabbit anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody conjugated to HRP (1 : 2000 dilution; Abcam). The chemiluminescence reaction was visualized by enhanced chemiluminescence (ECL) according to the manufacturer's instructions (Pharmacia).
Transient transfection assays. To generate a CAT reporter construct based on the HIV-MN LTR, a PCR product encompassing the HIV-MN LTR was subcloned into pSVOCAT (Clontech). THP1 cells (1610 7 ) in PBS were transfected by electroporation in prechilled 4 mm cuvettes (960 mF, 250 V) with 5 mg LTR-CAT reporter plasmid. Transfected cells were incubated on ice for 15 min and then transferred to warm medium. Cells were harvested at 48 h post-transfection and lysed by three cycles of freezing and thawing. CAT activity was determined using equivalent amounts of protein. Acetylated and non-acetylated CAT species were separated by thinlayer chromatography and spots were quantified using InstantImager (Packard).
Statistical analysis. The statistical significance of changes in total CCR5 protein levels in response to HCMV was assessed by a non-parametric approach. These data were initially analysed with Friedman's test and followed by examination of specific groups using the Dunn's multiple comparisons test.
RESULTS

HCMV infection of differentiated THP1 cells results in increased HIV-1 infection
To determine the exact effects of HCMV infection on subsequent infection with HIV-1 in myeloid cells, we used a myelomonocytic cell line (THP1), which is fully permissive for infection with HCMV when differentiated with PMA (Weinshenker et al., 1988; Turtinen & Seufzer, 1994) and which is also permissive for infection with HIV-1 (Asin et al., 2001) . Control differentiated THP1 cells or cells infected with HCMV Toledo for 48 h were superinfected with HIV-MN. Fig. 1 shows that infection of differentiated THP1 cells with HIV-1 resulted in expression of Gag protein, as detected by indirect immunofluorescence (Fig. 1b) . Interestingly, HCMV-infected cells expressing IE gene products were rarely found to express HIV-1 Gag (Fig. 1c) . In contrast, HCMV-uninfected bystander cells showed good levels of Gag expression and the amount of Gag expression appeared to be higher than levels of Gag expression in HIV-MN-infected cells that had not been exposed previously to HCMV (compare Fig. 1b and d) . Confirmation of increased Gag expression in cultures previously infected with HCMV was carried out by Western blot analysis (Fig. 1e) . The failure of THP1 cells to express HIV-1 Gag whilst expressing IE gene products and the apparently increased Gag levels in HCMV-uninfected bystander cells suggested that HCMV infection not only repressed subsequent infection with HIV-1 but also stimulated HIV-1 superinfection of HCMV-uninfected bystander cells.
HCMV activates the HIV-1 LTR in monocytic cells
One explanation for the observation that prior HCMV infection decreases HIV-1 Gag expression in HCMVinfected cells could be that, in this system, HCMV represses transcription from the HIV-1 LTR. To date, the ability of HCMV to activate the HIV-1 LTR has only been shown for LTR constructs based on T-cell-tropic strains of HIV. Therefore, we demonstrated that HCMV was also able to activate the HIV-1 LTR from a myelotropic strain of HIV-1 in myeloid cells. PCR amplification of an LTR from the myelotropic MN strain of HIV-1 was carried out and cloned upstream of a CAT reporter gene. Fig. 2 clearly shows that, as expected, HCMV superinfection of the monocytic THP1 cell line also resulted in LTR activation. These data suggested that the decrease in HIV-1 Gag expression in cultures previously infected with HCMV was not the result of inhibition of the HIV-1 LTR. 
HCMV infection of monocytic cells modulates CCR5 expression
HCMV infection is known to downregulate expression and transport of a number of cell-surface proteins including MHC class I, tumour necrosis factor receptor 1 (TNFRI) (Baillie et al., 2003) and epidermal growth factor receptor (EGFR) (Fairley et al., 2002) . The finding that HCMV infection prevented superinfection with HIV-MN could be the result of a deregulation in HIV-1 receptors, thereby preventing HIV-1 from entering the HCMV-infected cell. To address this issue, we determined whether receptors/coreceptors for HIV-1 infection on monocytes were altered during HCMV infection. FACS analysis was carried out on HCMV Toledo-infected or uninfected differentiated THP1 cells at 48 h p.i., stained with anti-CCR5 (a known coreceptor for HIV-1 infection of monocytic cells) and/or anti-MHC class I (as an indicator of HCMV infection). THP1 cells showed a low but reproducible level of CCR5 staining (17±6?2 %, n=4; data are expressed as mean±SEM) (Fig. 3, compare a and c) . Consistent with known observations, infection with HCMV resulted in a subpopulation of cells with reduced class I expression (population x) (Fig. 3 , compare e and f). Staining of parallel cultures with an anti-IE protein antibody showed approximately 50 % infection with HCMV (data not shown). Intriguingly, cells with reduced class I also had reduced CCR5 cell-surface expression (Fig. 3h , compare populations x and y), whilst uninfected bystander cells (Fig. 3h , population y) in culture displayed increased levels of CCR5 expression. These data suggested that HCMV infection of monocytic cells results in downregulation of surface CCR5 expression on infected cells accompanied by an increase on uninfected bystander cells within the HCMV-infected cultures.
The decrease in cell-surface expression of CCR5 on HCMVinfected cells was in good agreement with a reduction in Gag co-expression in HCMV-infected cells superinfected with HIV-1, whilst the increase in bystander cell CCR5 levels was consistent with an overall increase in Gag expression observed in HCMV-infected cultures after HIV-1 superinfection (Fig. 1) .
Modulation of CCR5 surface expression by HCMV reflects changes in intracellular protein levels in infected cells but not uninfected bystander cells
Our findings suggested that HCMV infection resulted in a decrease in cell-surface CCR5 on infected cells and an increase on uninfected bystander cells. We next determined whether these changes were also reflected in total levels of CCR5. First, we analysed CCR5 protein levels on fixed and permeabilized differentiated THP1 cells infected with HCMV or uninfected cells by FACS analysis. THP1 cells were differentiated overnight with PMA and then infected with CR[IE1-GFP] (m.o.i. of 5-10) or mock infected. At 48 h p.i., cells were harvested, fixed, permeabilized and stained for CCR5 expression. FACS analysis demonstrated that changes in surface CCR5 levels on HCMV-infected cells were concomitant with changes in intracellular protein levels. HCMV infection of monocytic cells resulted in a significant (n=3, P<0?05) downregulation of CCR5 protein levels. In contrast, the increase in the level of CCR5 cell-surface expression on uninfected bystander cells in an HCMV-infected population, which we observed in Fig. 3 , was not reflected by changes in levels of total CCR5 protein (Fig. 4a) .
We also confirmed this FACS analysis of total CCR5 protein in fixed and permeabilized cells by Western blot analysis. THP1 cells infected with CR[IE1-GFP] were sorted into IE1-GFP-positive and -negative populations at 48 h p.i. and analysed for CCR5 protein levels (Fig. 4b) . This clearly showed that, in IE1-positive cells (Fig. 4b, lane 3) , total steady-state levels of CCR5 were substantially reduced. Once again, uninfected bystander cells (Fig. 4b, lane 2) showed little change in overall levels of CCR5 compared with uninfected control cells (Fig. 4b, lane 1) .
HCMV increases CCR5 expression on primary macrophages
Although the THP1 cell line is of myelomonocytic lineage and does differentiate with phorbol esters to macrophagelike cells, we wanted to confirm the change in CCR5 levels using primary macrophages. MDMs, generated by in vitro differentiation of PBMCs using long-term culture in the presence of hydrocortisone and PMA, were infected with HCMV TB40/E (Fig. 5) . FACS analysis of control and HCMV-infected cultures for CCR5 and class I expression confirmed the HCMV-induced increase in CCR5 expression on uninfected bystander cells. MDMs were found to express good levels of CCR5 (Fig. 5a ) and class I (Fig. 5b) , which were reduced following infection with HCMV TB40/E ( Fig. 5c and d) . Furthermore, HCMV-infected MDMs expressing reduced class I displayed a total loss of CCR5 surface expression (Fig. 5e) , whilst uninfected bystander cells, expressing normal levels of class I, displayed increased CCR5 expression (Fig. 5f ) compared with uninfected controls (Fig. 5a ).
Soluble factor(s) produced during HCMV infection of monocytic cells induce increased CCR5 and Gag expression on uninfected bystander cells
To assess whether soluble factor(s) released by the HCMVinfected cells within the cell population could be responsible for the induction of CCR5 expression on uninfected bystander cells, differentiated THP1 cells were mock inoculated or inoculated with HCMV CR[IE1-GFP] and cell-free supernatants were harvested at 48 h p.i. Differentiated THP1 cells were then cultured in the presence of these supernatants for 48 h and surface stained to detect CCR5. FACS analysis clearly demonstrated that supernatant harvested at 48 h after HCMV infection induced a similar increase in CCR5 levels on differentiated THP1 cells (Fig. 6c) to that seen on bystander cells during HCMV infection (Fig. 6e) , whilst supernatants from mock-infected cells did not modulate CCR5 expression (Fig. 6c ) compared with uninfected controls (Fig. 6a) .
We also determined whether this increase in CCR5 expression mediated by soluble factor(s) released into HCMVinfected supernatants had any effect on their ability to be superinfected with HIV-1. Interestingly, immunofluorescence microscopy indicated increased intensity of Gag expression after HIV-1 superinfection of THP1 cells treated with HCMV-conditioned supernatants (Fig. 7a) . Differentiated THP-1 cells were pre-treated with control media or with HCMV-conditioned media or infected with HCMV Toledo and superinfected with HIV-MN 48 h later. At 72 h p.i., cells were stained for Gag expression. Increased Gag staining was observed in cells pre-treated with supernatants from HCMV-infected cells [Fig. 7a, panel (v) ] compared with medium controls [Fig. 7a , panels (i) and (ii)]. We confirmed these immunofluorescence assays quantitatively by FACS analysis (Fig. 7b) . Consistent with the immunofluorescence analysis, HIV infection of control differentiated THP1 cells led to readily detectable levels of Gag expression (Fig. 7b, 29 % of cells, histogram 2), which was increased by pre-treatment of cells with HCMVconditioned medium (Fig. 7b, 56 % of cells, histogram 3) and also increased by HCMV infection (Fig. 7b, 52 % of cells, histogram 4). We also quantified the level of HCMV infection in these samples by IE1 detection, which showed no IE expression in untreated cells or in cells treated with HCMV-conditioned medium and 12 % infection with HCMV in HCMV-infected cells. Similarly, cells that were not inoculated with HIV-MN showed no Gag staining (data not shown). These data suggest that soluble factor(s) produced during HCMV infection of monocytic cells mediate the increase in surface levels of CCR5 on bystander cells, which results in these cells showing higher levels of Gag expression on co-infection with HIV-MN.
DISCUSSION
In order to investigate further the well-documented interplay between HIV-1 and HCMV, we analysed the effect of HCMV infection of myeloid cells on their subsequent infection with HIV-1. Our data demonstrated that infection of myeloid cells with HCMV increased the levels of HIV-1 Gag expression after superinfection with HIV-1. This increase was found to be restricted to the HCMV-uninfected bystander cell population. In contrast, cells expressing the IE gene products IE72/IE86 showed little or no HIV-1 gene expression. Furthermore, the lack of Gag expression in these cells was not due to transcriptional repression of the HIV-MN LTR by HCMV. FACS analysis of CCR5 co-receptor levels on live cells indicated that HCMVinfected cells had reduced levels of surface CCR5, whilst uninfected bystander cells in the culture had increased levels of surface CCR5 compared with uninfected controls.
Our observation that HCMV infection of macrophages downregulated levels of surface CCR5 is consistent with previous work by Lecointe et al. (2002) who showed that primary MDMs infected with HCMV AD169 exhibited downregulation of plasma membrane expression of CCR5 with no change in surface CD4 expression. Similarly, HCMV infection of dendritic cells (Varani et al., 2005) , astrocytes and microglia (Lecointe et al., 2002) also results in a decrease in surface CCR5 levels. The role of CCR5 in virus infections is unclear. Downregulation of CCR5 on the cell surface has been demonstrated to protect cells from HIV envelopemediated apoptosis (Algeciras-Schimnich et al., 2002) , whilst CCR5-CCL5 interactions have been shown to protect macrophages from respiratory syncytial virus-and influenza virus-induced cell death (Tyner et al., 2005) . Modulation of CCR5 by multiple HCMV strains and in cell lines and primary cells is intriguing and suggests that CCR5 might have an as yet unknown biological significance during HCMV infection.
HCMV-infected cells express low levels of CCR5 -either HCMV only infects low-CCR5-expressing cells or it represses CCR5 expression. To address the possibility that HCMV preferentially infected cells with low levels of CCR5 expression, we aseptically sorted live differentiated THP1 cells based on high or low CCR5 expression by FACS. Cultures of low and high CCR5-expressing THP1 cells were then infected with HCMV CR[IE1-GFP] and the number of IE1-expressing cells was assessed at 48 h p.i. Both populations of THP1 cells were permissive to HCMV (data not shown). In addition, analysis of total (surface and intracellular) CCR5 protein in permeabilized cells by FACS analysis demonstrated that HCMV infection resulted in a significant decrease in CCR5 protein in infected cells. CCR5 has been shown to exist in two forms, a 42 kDa form suggested to be present in the cytoplasm of cells and a 62 kDa form that resides mainly on the cell surface (Suzuki et al., 2002) . Western blot analysis of CCR5 in IE1-expressing versus bystander cells clearly demonstrated that the 42 kDa form is decreased in IE1-positive cells compared with uninfected controls. Interestingly, increases in cell-surface expression of CCR5 on uninfected bystander cells was not reflected by changes in the total amount of CCR5 protein. The mechanism by which total CCR5 versus cell-surface expression is differentially affected by HCMV depending on whether the cell is itself infected or is an uninfected bystander is at present unclear. We were unable to detect the 62 kDa form of CCR5, consistent with the observed low levels of CCR5 present on the surface of THP1 cells and the indication that the 62 kDa form is more readily detectable under non-reducing conditions (Suzuki et al., 2002) . The promoter region of CCR5 contains multiple binding sites for a variety of transcription factors including YY1 (Moriuchi & Moriuchi, 2003; Lei et al., 2005) , Oct-1, Oct-2 (Moriuchi & Moriuchi, 2001 ), T-cell factor 1a and GATA1 (Moriuchi et al., 1997) . The observed reduction in CCR5 protein levels following HCMV infection could be the result of upregulation of negative-regulating transcription factors, a decrease in the stability of CCR5 mRNA or an increase in protein degradation. Current studies in our laboratory are under way to investigate the mechanism(s) of HCMV-induced CCR5 downregulation. In contrast to HCMV-infected cells, uninfected bystander cells displayed increased levels of surface expression but had unchanged total levels of CCR5. To extend the relevance of our findings, we confirmed the HCMV-induced changes in CCR5 expression using HCMV-infected primary MDMs. MDMs exhibit similar changes in CCR5 expression on infected and uninfected cells.
We tested whether soluble factor(s) released by the HCMVinfected cells within the population could be responsible for the induction of CCR5 expression on uninfected bystander cells. Differentiated THP1 cells exhibited increased Gag expression after HIV-1 superinfection if HCMVconditioned medium was used in place of virus. This suggests that a factor or factors produced during HCMV infection of monocytic cells is, at least in part, responsible for the observed increase in bystander CCR5 expression. Furthermore, indirect immunofluorescence experiments and quantitative FACS analysis demonstrated that the upregulation in CCR5 surface expression on bystander cells by conditioned medium also resulted in an increase in HIV-1 Gag expression after HIV-1 superinfection. The exact nature of the soluble factor(s) responsible is currently under investigation, but several soluble mediators have been shown to influence HIV-1 CCR5 co-receptor expression. For instance, both mRNA and protein expression of CCR5 were increased in monocytes/macrophages in response to interleukin 2 (IL-2) (Weissman et al., 2000) and IL-10 (Percherancier et al., 2001) and are augmented by gamma interferon (Hariharan et al., 1999) and tumour necrosis factor alpha (TNF-a) (Croitoru-Lamoury et al., 2003) . Furthermore, HCMV encodes a biologically active viral IL-10 homologue (Spencer et al., 2002) that has been demonstrated to bind the IL-10 receptor (Kotenko et al., 2000) . Similarly, TNF-a produced by HCMV-infected PBMCs obtained from HCMV-infected donors has been shown to induce HIV-1 replication (Peterson et al., 1992) .
Our observations suggest that HCMV infection results in the release of soluble factor(s) that are able to mediate increased CCR5 surface expression on uninfected bystander cells. However, the HCMV-infected cells themselves are refractory to such stimuli. From preliminary experiments, we favour the hypothesis that HCMV infection inhibits expression of CCR5 in the infected cell, thereby protecting or 'isolating' the infected cell from any external signals, ensuring an optimal environment for virus replication and dissemination. Downregulation of CCR5 also appears to protect the cells from subsequent HIV-1 infection, as determined by Gag expression. We note that this occurs even in the presence of viral US28 expression, which has been shown to act as a co-receptor for HIV-1 in transfected U373 cells (Pleskoff et al., 1997) .
Modulation of cell-surface receptors by HCMV is not uncommon and our laboratory has previously shown downregulation of surface TNFRI and EGFR by HCMV (Fairley et al., 2002; Baillie et al., 2003) . It is clear that HCMV specifically targets multiple host surface receptors and such modulation most likely confers a survival advantage.
Taken together, our data suggest that prior infection with HCMV and subsequent reactivation during the immunocompromised state of HIV-positive patients may contribute to the pathogenesis of AIDS by modulating CCR5 co-receptor levels on neighbouring cells and thus promoting HIV dissemination and replication. We speculate that CCR5 modulation by HCMV in vitro in both monocytic cells and primary MDMs leads to a direct increase in HIV-MN gene expression following superinfection. Due to conflicting studies, it remains unclear how HCMV influences HIV-1 infection in vivo. Much of the work to date was carried out using pseudotyped HIV-1 and cell lines that cannot normally be infected with HIV-1. The present study employed primary HCMV and HIV target cells, as well as a fully permissive cell line, coupled with naturally infectious virus strains, to investigate the interplay between these two important viral pathogens.
